Lizán L - Search Results

1

What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis.

Díaz-Torné C, Urruticoechea-Arana A, Ivorra-Cortés J, Díaz S, Dilla T, Sacristán JA, Inciarte-Mundo J, Comellas M, Prades M, Lizán L. Díaz-Torné C, et al. Among authors: lizan l. Adv Ther. 2020 Apr;37(4):1479-1495. doi: 10.1007/s12325-020-01258-5. Epub 2020 Feb 22. Adv Ther. 2020. PMID: 32088860 Free PMC article.

2

[Concept and tools].

Lizán L, Paz S, Dilla T, Rodríguez JM, Lahoz R, Reig-Ferrer A. Lizán L, et al. Aten Primaria. 2009 May;41(5):275-80. doi: 10.1016/j.aprim.2008.06.006. Epub 2009 Apr 29. Aten Primaria. 2009. PMID: 19403202 Free PMC article. Spanish. No abstract available.

3

[Treatment adherence and persistence: causes, consequences and improvement strategies].

Dilla T, Valladares A, Lizán L, Sacristán JA. Dilla T, et al. Among authors: lizan l. Aten Primaria. 2009 Jun;41(6):342-8. doi: 10.1016/j.aprim.2008.09.031. Epub 2009 May 7. Aten Primaria. 2009. PMID: 19427071 Free PMC article. Spanish. No abstract available.

4

Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.

Lizán L, Comellas M, Paz S, Poveda JL, Meletiche DM, Polanco C. Lizán L, et al. Patient Prefer Adherence. 2014 Dec 4;8:1653-64. doi: 10.2147/PPA.S67253. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 25525341 Free PMC article. Review.

5

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population.

Dilla T, Lizan L, Paz S, Garrido P, Avendaño C, Cruz-Hernández JJ, Espinosa J, Sacristán JA. Dilla T, et al. Among authors: lizan l. Patient Prefer Adherence. 2015 Dec 18;10:1-7. doi: 10.2147/PPA.S93760. eCollection 2016. Patient Prefer Adherence. 2015. PMID: 26719677 Free PMC article.

6

Expert Consensus on the Management of Patients with Postmenopausal Osteoporosis in the Spanish Healthcare System.

Del Pino-Montes J, Blanch J, Nogués X, Moro MJ, Valero Mdel C, Canals L, Lizán L. Del Pino-Montes J, et al. Among authors: lizan l. Adv Ther. 2016 Apr;33(4):658-69. doi: 10.1007/s12325-016-0314-9. Epub 2016 Mar 17. Adv Ther. 2016. PMID: 26984314

7

Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population.

Dilla T, Lizán L, Paz S, Garrido P, Avendaño C, Cruz JJ, Espinosa J, Sacristan JA. Dilla T, et al. Among authors: lizan l. Value Health. 2014 Nov;17(7):A327. doi: 10.1016/j.jval.2014.08.592. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200550 Free article. No abstract available.

8

Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 1 Diabetes Mellitus In Spain.

Ramírez de AA, Lizán L, Prades M, Morales C, De LD. Ramírez de AA, et al. Among authors: lizan l. Value Health. 2014 Nov;17(7):A343. doi: 10.1016/j.jval.2014.08.687. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200636 Free article. No abstract available.

9

Cost of Health Care Services Offered by Parkinson Disease Associations in Spain.

Galvez M, Prades M, Paz S, Lizán L. Galvez M, et al. Among authors: lizan l. Value Health. 2014 Nov;17(7):A397. doi: 10.1016/j.jval.2014.08.892. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200934 Free article. No abstract available.

10

Costs of Psoriasis in Europe. A Systematic Review of the Literature.

Obradors M, Figueras M, Paz S, Comellas M, Lizán L. Obradors M, et al. Among authors: lizan l. Value Health. 2014 Nov;17(7):A606. doi: 10.1016/j.jval.2014.08.2112. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202102 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page